Adipotide (TP01/FTPP) is an experimental peptidomimetic agent designed to treat obesity by selectively inducing apoptosis (programmed cell death) in the blood vessels of white fda approved Adipotide (FTPP) 10mg PEPTIDE fda approved ACE-031 PEPTIDE adipose tissue. Studies in monkeys showed rapid weight loss (over 11% in 28 days) and improved insulin resistance. It is currently an investigational compound not approved for human use.